--- a
+++ b/Manuscripts/CDS-Bevacizumab-LLMs/README.md
@@ -0,0 +1,25 @@
+<div align="left">
+
+<br>
+  
+Kawchak K. Clinical decision support based on Bevacizumab cancer trials and pushing the limitations of advanced LLMs. Zenodo. 2025; doi:10.5281/zenodo.14968162 This content is a preprint and has not been peer-reviewed. Creative Commons Attribution 4.0 International.
+
+[![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.14968162.svg)](https://doi.org/10.5281/zenodo.14968162)
+
+
+
+<div align="left">
+
+<br>
+  
+Kawchak K. Gemini Update Clinical decision support based on Bevacizumab cancer trials and pushing the limitations of advanced LLMs. Zenodo. 2025; doi:10.5281/zenodo.14968289 This content is a preprint and has not been peer-reviewed. Creative Commons Attribution 4.0 International. [Full Study](https://doi.org/10.5281/zenodo.14968162)
+
+[![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.14968289.svg)](https://doi.org/10.5281/zenodo.14968289)
+
+
+
+
+## AI Applications for Drug Industry
+LLM and LLM agent pharmaceutical industry applications
+
+[![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.13273141.svg)](https://doi.org/10.5281/zenodo.13273141)